BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31562946)

  • 1. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
    Oh Y; Choi S; Cho MY; Nam KA; Shin SJ; Chang JS; Oh BH; Roh MR; Chung KY
    J Am Acad Dermatol; 2020 Oct; 83(4):1071-1079. PubMed ID: 31562946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
    Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
    Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
    World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.
    Ipenburg NA; Lo SN; Vilain RE; Holtkamp LHJ; Wilmott JS; Nieweg OE; Thompson JF; Scolyer RA
    J Am Acad Dermatol; 2020 Apr; 82(4):910-919. PubMed ID: 31682859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-varying pattern of recurrence risk for localized melanoma in China.
    Wen X; Li D; Zhao J; Li J; Yang T; Ding Y; Peng R; Zhu B; Huang F; Zhang X
    World J Surg Oncol; 2020 Jan; 18(1):6. PubMed ID: 31901239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
    Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
    Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for metastasis in cutaneous melanoma.
    Cherobin ACFP; Wainstein AJA; Colosimo EA; Goulart EMA; Bittencourt FV
    An Bras Dermatol; 2018; 93(1):19-26. PubMed ID: 29641692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
    Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
    J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
    Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome following local recurrence or in-transit metastases in cutaneous melanoma.
    Suojärvi NJ; Jahkola TA; Virolainen S; Ilmonen SK; Hernberg MM
    Melanoma Res; 2012 Dec; 22(6):447-53. PubMed ID: 23059832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.